Randomized trial comparing natural and synthetic surfactant: Increased infection rate after natural surfactant?

Acta Paediatrica, International Journal of Paediatrics

Volumn 89, Issue 5, 2000, Pages 556-561

  Kukkonen, A K ^a   Virtanen, M ^b   Jarvenpaa A L ^c   Pokela, M L ^d   Ikonen, S ^e   Fellman, V ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c Helsinki City Maternity Hospital   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

C reactive protein; Newborn infant; Respiratory distress syndrome; Septicaemia; Surfactant therapy

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; C REACTIVE PROTEIN; DOBUTAMINE; DOPAMINE; LUNG SURFACTANT EXTRACT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B;

AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INFANT; INFECTION RATE; INFECTION RISK; LEUKOPENIA; LUNG ALVEOLUS OXYGEN TENSION; MAJOR CLINICAL STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

BIOLOGICAL PRODUCTS; C-REACTIVE PROTEIN; DRUG COMBINATIONS; FATTY ALCOHOLS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LEUKOPENIA; MALE; PHOSPHOLIPIDS; PHOSPHORYLCHOLINE; POLYETHYLENE GLYCOLS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK; SEPSIS; THROMBOCYTOPENIA;

EID: 0033898862     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2000.tb00338.x     Document Type: Article

References (27)

1. Pulmonary surfactant therapy
2. Artificial surfactant therapy in hyaline membrane disease
3. Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective trial
4. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome
5. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome
6. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: A 1992 update
7. Multicenter randomised trial comparing high and low dose regimens for the treatment of respiratory distress syndrome (The Curosurf 4 trial)
8. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome
9. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome; single versus multiple doses of Curosurf
10. Early versus delayed neonatal administration of a synthetic surfactant - The judgement of OSIRIS
11. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome
12. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome
13. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome
14. Natural vs synthetic surfactants in neonatal respiratory distress syndrome. Review article
15. Idiopathic respiratory distress syndrome in the newborn
16. Randomized study of high-frequency oscillatory ventilation in infants with severe respiratory distress syndrome
17. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1500 g
18. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging
19. Bronhopulmonary dysplasia
20. Exosurf versus Survanta surfactant preparations: Proportional-hazards regression analysis of time to successful extubation and discontinuation of oxygen therapy
21. Natural exogenous surfactant therapy stimulates the acute phase reaction in premature neonates
22. Incidence of neonatal infections in very low birthweight infants with severe RDS treated with natural porcine surfactant
23. The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials
24. Modified natural surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes
25. Chemiluminescence activity of phagocytes from tracheal aspirates of premature infants after surfactant therapy